
LEO Pharma Announces FDA Approval Of ANZUPGO® (Delgocitinib) Cream In The U.S.
(MENAFN- AETOSWire) (BUSINESS WIRE )--LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has approved ANZUPGO ® (delgocitinib) cream (20 mg/g) for the topical treatment of moderate-to- …